Table 3.
Study year | Study code | Index case | Age, years | Sex | Clinical classification | IgM1 | IgM2 | InhE1titer | InhE2 titer | Result InhE | Primary/secondary infection | RT-PCR | Virus isolation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2006–2007 | 20002 | 276 | 30 | F | AS | + | + | 5 | 1,443 | + | 1 | – | NP |
20032 | 2510† | 13 | M | AS | – | – | 200 | 7,563 | + | 2 | DENV-2 | DENV-2 | |
20065 | 3325 | 24 | F | AS | – | + | 1,550 | 3,933 | – | 2 | – | NP | |
20131 | 3555† | 40 | F | AS | – | – | 15 | 211 | + | 1 | – | NP | |
2007–2008 | 20170 | 1565 | 14 | F | AS | – | – | 2,862 | 100,001 | + | 2 | DENV-2 | DENV-2 |
20172 | 1565 | 11 | F | UFI | – | + | 2,011 | 36,547 | + | 2 | DENV-2 | DENV-2 | |
20213 | 2703 | 14 | F | DF‡ | – | + | 345 | 100,001 | + | 2 | DENV-2 | DENV-2 | |
20410 | 2453 | 25 | F | DF | – | + | 296 | 16,099 | + | 2 | DENV-2 | DENV-2 | |
20443 | 1155 | 67 | F | DF | – | + | 12,724 | 33,942 | – | 2 | DENV-2 | – | |
20497 | 2538 | 12 | F | DF‡ | – | + | 316 | 18,634 | + | 2 | DENV-2 | DENV-2 | |
20498 | 2538 | 14 | F | UFI | – | + | 1,561 | 5,092 | – | 2 | DENV-2 | – | |
20502 | 2538 | 15 | M | UFI‡ | – | – | 4,154 | 20,180 | + | 2 | DENV-2 | – |
InhE = inhibition enzyme-linked immunosorbent assay; RT-PCR = reverse transcription–polymerase chain reaction; AS = asymptomatic; NP = not processed; DENV = dengue virus; UFI = undifferentiated febrile illness; DF= dengue fever.
Negative index case.
Febrile at enrollment.